Predictive Biosciences Adds PCR to Protein Assay to Improve Performance of Bladder Cancer Test

The company found that it could improve the negative predictive value of its bladder cancer test from 94 percent with the protein-based assay alone to 97 percent with the combined approach.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.